Abbott's Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as ...

The Volt PFA system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced it received CE mark approval in Europe for its ...

Abbott today announced it has received CE Mark in Europe for the Volttm PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has begun ...

Revenue increased steadily: The revenue of the Group was approximately RMB1,303.7 million for the year ended 31 December 2024, representing a year-on-year growth of approximately 2.9%.

"Clinical data has also shown that the Volt catheter's cutting-edge design helps ... 13F sizing of the company's Agilis™ NxT Steerable Introducer, Dual Reach™, which makes the Agilis system ...

Precision Introducer, 20G x 3.2cm, 10/cs (Drop Ship Requires Pre-Approval) Precision Introducer, 18G x 3.2cm, 10/cs (Drop Ship Requires Pre-Approval) Precision Introducer, 16G x 3.2cm, 10/cs (Drop ...

The Volt PFA System builds upon Abbott's leading electrophysiology (EP) portfolio by providing a single-catheter PFA approach, improving workflow by allowing for mapping, pacing, and ablating with ...

After hours: March 26 at 4:05:11 PM EDT Loading Chart for ANGO ...